The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation

被引:759
作者
Welcker, M
Orian, A
Jin, JP
Grim, JA
Harper, JW
Eisenman, RN
Clurman, BE
机构
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA
[3] Fred Hutchinson Canc Res Ctr, Dept Basic Sci, Seattle, WA 98109 USA
[4] Univ Washington, Sch Med, Dept Med, Seattle, WA 98104 USA
[5] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
关键词
D O I
10.1073/pnas.0402770101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Myc proteins regulate cell growth and division and are implicated in a wide range of human cancers. We show here that Fbw7, a component of the SCFFbw7 ubiquitin ligase and a tumor suppressor, promotes proteasome-dependent c-Myc turnover in vivo and c-Myc ubiquitination in vitro. Phosphorylation of c-Myc on threonine-58 (T58) by glycogen synthase kinase 3 regulates the binding of Fbw7 to c-Myc as well as Fbw7-mediated c-Myc degradation and ubiquitination. T58 is the most frequent site of c-myc mutations in lymphoma cells, and our findings suggest that c-Myc activation is one of the key oncogenic consequences of Fbw7 loss in cancer. Because Fbw7 mediates the degradation of cyclin E, Notch, and c-Jun, as well as c-Myc, the loss of Fbw7 is likely to elicit profound effects on cell proliferation during tumorigenesis.
引用
收藏
页码:9085 / 9090
页数:6
相关论文
共 44 条
[1]   c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover [J].
Bahram, F ;
von der Lehr, N ;
Cetinkaya, C ;
Larsson, LG .
BLOOD, 2000, 95 (06) :2104-2110
[2]  
BHATIA K, 1994, BLOOD, V84, P883
[3]   POINT MUTATIONS IN THE C-MYC TRANSACTIVATION DOMAIN ARE COMMON IN BURKITTS-LYMPHOMA AND MOUSE PLASMACYTOMAS [J].
BHATIA, K ;
HUPPI, K ;
SPANGLER, G ;
SIWARSKI, D ;
IYER, R ;
MAGRATH, I .
NATURE GENETICS, 1993, 5 (01) :56-61
[4]   The c-myc transactivation domain is a direct modulator of apoptotic versus proliferative signals [J].
Chang, DW ;
Claassen, GF ;
Hann, SR ;
Cole, MD .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (12) :4309-4319
[5]   DEGRADATION OF NUCLEAR ONCOPROTEINS BY THE UBIQUITIN SYSTEM INVITRO [J].
CIECHANOVER, A ;
DIGIUSEPPE, JA ;
BERCOVICH, B ;
ORIAN, A ;
RICHTER, JD ;
SCHWARTZ, AL ;
BRODEUR, GM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (01) :139-143
[6]   Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation [J].
Clurman, BE ;
Sheaff, RJ ;
Thress, K ;
Groudine, M ;
Roberts, JM .
GENES & DEVELOPMENT, 1996, 10 (16) :1979-1990
[7]   myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome [J].
Flinn, EM ;
Busch, CMC ;
Wright, APH .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (10) :5961-5969
[8]   Protein stabilization: a common consequence of mutations in independently derived v-Myc alleles [J].
Gavine, PR ;
Neil, JC ;
Crouch, DH .
ONCOGENE, 1999, 18 (52) :7552-7558
[9]   Werner syndrome protein limits MYC-induced cellular senescence [J].
Grandori, C ;
Wu, KJ ;
Fernandez, P ;
Ngouenet, C ;
Grim, J ;
Clurman, BE ;
Moser, MJ ;
Oshima, J ;
Russell, DW ;
Swisshelm, K ;
Frank, S ;
Amati, B ;
Dalla-Favera, R ;
Mormat, RJ .
GENES & DEVELOPMENT, 2003, 17 (13) :1569-1574
[10]   c-Myc proteolysis by the ubiquitin-proteasome pathway: Stabilization of c-Myc in Burkitt's lymphoma cells [J].
Gregory, MA ;
Hann, SR .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (07) :2423-2435